Enable Injections
enableinjections.com
Actively hiring
Science & Engineering
Infusion & Drug Delivery Devices
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
The Needle You Never See: Inside the enFuse System
As more therapies transition from intravenous (IV) infusion to subcutaneous (SC) administration, the conversation around drug delivery continues to evolve. Advances in biologics, formulation science, and wearable drug delivery technologies have expanded w
Read more
Report
Press Release: Sanofi's subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector
Sanofi's subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector Sarclisa Escena administered via the CirCLIQ on-body injector (OBI) offers a...
Read more
Report
Press Release: Sanofi's Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector
Sarclisa SC approved in EU: first anticancer via on-body injector CirCLIQ. Flexible home/clinic administration for multiple myeloma patients.
Read more
Report
Enable Injections Announces CE Certification of the enFuse On-Body Delivery System for Use with Aspaveli Distributed by Sobi
Regulatory milestone expands access to wearable, patient-centric drug delivery for rare disease treatment across Europe CINCINNATI, May 22, 2026 (GLOBE NEWSWIRE) - Enable Injections, Inc. ("Enable"), a healthcare innovation company developing and manufact
Read more
Report
Enable Injections Announces CE Certification of the enFuse On-Body Delivery System for Use with Aspaveli Distributed by Sobi
Regulatory milestone expands access to wearable, patient-centric drug delivery for rare disease treatment across Europe...
Read more
Report
Pro access
Upgrade to see all 31 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People
Susan Spies
Executive Officer
Timothy Flaherty
Executive Officer
Michael Hooven
Executive Officer, Director
David Kroekel
Executive Officer
Matt Huddleston
Executive Officer
Richard D'Augustine
Director
Mark Collar
Director
Norman Weldon
Director
John Rice
Director
Daniel von Allmen
Director
Simone Song
Director
Karen Robards
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Financials
Total raised
$270M
Latest round
Venture - Series Unknown
Funding rounds
10
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2025 | $30M | Details |
| Venture - Series Unknown | 2022 | $150M | Details |
| Venture - Series Unknown | 2018 | $30.7M | Details |
| Venture - Series Unknown | 2016 | $25M | Details |
| Venture - Series Unknown | 2016 | $25M | Details |
| Venture - Series Unknown | 2016 | $5M | Details |
| Venture - Series Unknown | 2015 | $247k | Details |
| Venture - Series Unknown | 2014 | $2M | Details |
| Venture - Series Unknown | 2014 | $23k | Details |
| Venture - Series Unknown | 2012 | $2M | Details |